Health
Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication – News-Medical.Net
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
The devastating impact of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to significant efforts to curb its transmission. When RNA viruses, like the SARS-CoV-2, replicate there could be versions of the virus that have large deletions in the viral genome,…
-
General14 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News20 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Noosa News22 hours agoVictorian farmer to auction father’s vintage tractor collection
-
Noosa News22 hours agoPolice urging motorists to drive responsibly, as every life taken is one too many